Market Times:

London:

New York:

Singapore:

BitMine Unveils $1B Stock Buyback Plan to Bolster Ethereum Strategy

The company's shares witnessed notable decline following the announcement suggesting that investors may be concerned about near-term execution risks or broader market uncertainty.

Ethereum GameSquare SharpLink Bitmine

BitMine Immersion Technologies has unveiled a $1 billion stock buyback plan aimed at enhancing its crypto-assets-per-share ratio. The board-approved program is open-ended, giving the company flexibility to repurchase shares at its discretion based on market conditions. 

“In our road to achieving ‘the alchemy of 5%’ of ETH, there may be times when the best expected return of our capital is to acquire our own shares,” the company’s chairman, Thomas “Tom” Lee stated. 

However, some analysts expressed skepticism despite the bullish plan. Shares of BMNR dropped approximately 11% following the announcement. The decline suggests that investors may be concerned about near-term execution risks or broader market uncertainty.

Bullish on Ethereum 

Following its strategic pivot from Bitcoin mining to Ethereum treasury accumulation, BitMine has aggressively acquired the altcoin in several purchases. This shift has led the firm to amass 625,000 ETH at an average price of $3,755 per ETH. This stash is worth approximately $2.36 billion based on the current market price. 

Meanwhile, BitMine’s current financial position includes $401.4 million in unencumbered cash. Its net asset value (NAV) per share stands at $22.76, derived from a mix of cash and crypto. The company also holds 192 BTC in its treasury. 

BitMine has been extremely bullish on ETH, suggesting the token may rise as far as $60,000 if the bull market continues. The firm’s aggressive ETH accumulation has positioned it as the largest public ETH treasury. Trailing BitMine is SharpLink, which holds approximately 438,190 ETH worth than $1.5 billion in its treasury. 

Biotech Firm to Establish ETH Treasury Reserve 

Following the footsteps of these firms, 180 Life Sciences, a biotech firm, announced an upsized $425 million private investment in public equity (PIPE) to establish an Ethereum-focused treasury reserve. This strategic move is backed by influential figures in the crypto and DeFi ecosystem.  Upon closing, the company will officially be renamed ETHZilla Corporation.

“The Company aims to differentiate itself from other Ethereum treasury strategy players by its commitment to and collaboration with the builders and allocators who have brought the ecosystem to prominence. As we arrive at the ten-year anniversary of Ethereum, we’re proud to partner with the Company to support a treasury strategy that will be community-designed and strategically deployed,” said Vivek Raman, CEO of Etherealize.

Get Trending Crypto News as It Happens. Follow CoinTab News on X (Twitter) Now

Faith

Faith is a dedicated content writer who is focused on expanding her interest and knowledge about cryptocurrencies and blockchain technology. In her free time, she enjoys listening to music, reading, and traveling.